1Laghmich A,Ladriere L,Malaisse-Lagae F,et al.Long-term effects of glibenclamide and nateglinide upon pancreatic islet function in normal and diabetic rats[J].Pharmacol Res.
3Del Prato S,Heine RJ,Keilson L,et al.Treatment of patients over 64 years of age weith type 2 diabetes experience from nateglinide pooled database retrospective analysis[J].Diabetes Care,2003,26(7):2075-2080.
6Devineni D,Walter Y H,Smith H T,er al.Pharmacok inetics of nateglinide in renally im paired diabetic patients[J].J Clin Pharmacol,2003,43(2):163-170.
二级参考文献35
1Petersen K, Sullivan J, Amatruda SJ, et al. 35th annual meeting of the european association for the study of diabetes[J]. Diabetologia,1999,42(Suppl.1): A1-A354.
2Druker DJ. The glucagon-like peptides[J]. Endocrinology,2001,142: 521-527.
3Miyawaki K, Yamada Y, Yano H, et al. Glucose intolerance caused by a defect in the entero-insular axis :a study in gastric inhibitory polypeptide knockout mice[J]. Proc Natl Acad Sci USA,1999,96: 14843-14847.
4Edwards CM, Todd JF, Mahmoudi M, et al. Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans[J]. Diabetes,1999,48: 86-93.
5Marguet D, Baggio L, Kobayashi T, et al. Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26[J]. Proc Ncad Sci USA,2000,97: 6874-6879.
6Stefanovic V, Antic S, Minnay JN, et al. Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes[J]. Cell, 1999,96: 329-339.
7Elchebly M,Payette P,Michaliszgn E,et al.Increased insulin sensitivity and obesity resistance in mice lacking the protein throsine phosphatase-1B gene[J].Science,1999,283: 1544-1548.
8Bush EN. Treatment of zucker diabetic fatty rats with antisense oligonucleotide to phosphotyrosine phosphatase 1B for 5 weeks halts development of diabetes[J]. Diabetes,2001, 50(Suppl2): A81-A87.
9Wswton CR, Davis RJ. Signalling specificity -a complex affair[J]. Science,2001,292: 2439-2440.
10Clement S, Krause U, Desmedt F, et al. The lipid phosphatase SHIP2 controls insulin sensitivity[J]. Nature,2001,409: 92-97.
